Tag: technology
-
Overcoming manufacturing bottlenecks in cell and gene therapy: The emergence of the intelligent development and manufacturing organization (IDMO) model in Asia
Yu-Hsiang Chang, Ph.D.Chief Executive Officer (CEO), Locus Cell Co., Ltd. Abstract The clinical efficacy of Chimeric Antigen Receptor T-cell (CAR-T) therapies has irrevocably transformed the landscape of oncology and personalized medicine. Despite these groundbreaking clinical successes, the broad accessibility of these advanced therapies is severely limited by traditional manufacturing paradigms. High production costs, reliance on…
-
From Formosa to the world: leading the new era of regenerative medicine and cellular therapy in Taiwan
Dr. Chen-Chie Wang, MD., Ph.D.President of Formosa Association of Regenerative Medicine (FARM)Director of Department of Orthopedic Surgery, Taipei Tzu Chi Hospital, New Taipei City, TaiwanDepartment of Orthopedics, School of Medicine, Hualien Tzu Chi University, Hualien, Taiwan Regenerative medicine has rapidly evolved from experimental concepts into a transformative force in standard clinical care, ushering in a new…
-
iPSC-derived cardiac cell sheets for heart regeneration: Progress towards clinical translation
Yuan-Yuan Cheng, Ph.D.International Ph.D. Program in Cell Therapy and Regenerative Medicine,College of Medicine, Taipei Medical University, Taiwan Abstract Background Heart disease remains the second leading cause of death worldwide. Currently, heart transplantation is considered the only definitive treatment for severe heart failure due to the poor heart regeneration after injury. Adult cardiomyocytes lose their proliferative…
-
Artificial Intelligence in Cell Therapy: Advancing Development, Manufacturing, and Clinical Translation
Yu-Xiu Lin, M.Sc & Thai-Yen Ling, Ph.D.Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taiwan Artificial intelligence (AI) is reshaping the life sciences industry at an unprecedented pace. Among the most transformative areas is cell and gene therapy (CGT), a field that promises curative approaches for cancer, genetic disorders, autoimmune diseases, and degenerative…
-
The New Era of Regenerative Medicine: Synergistic Development of Innovative Therapies and the National Health Insurance System
Lian-Yu Chen, M.D.,Ph.D.Director-GeneralNational Health Insurance Administration, Taiwan With the rapid development of regenerative medicine, innovative therapies are gradually transforming disease treatment paradigms. To address high-cost therapies associated with significant uncertainty, Taiwan’s National Health Insurance (NHI) has established corresponding reimbursement and management mechanisms. Cell and Gene Therapy: Opening a New Era of Medicine In recent years,…
-
From Policy Blueprint to Implementation: The Current Status and Future Outlook of Regenerative Medicine in Taiwan
Yueh-Ping LiuDepartment of Medical Affairs,Ministry of Health and Welfare, Taiwan To respond to the rapid advancement of frontier medical technologies and the public’s growing expectations for more comprehensive healthcare options, the Ministry of Health and Welfare (MOHW) has long been committed to establishing a transparent and data‑driven governance framework for emerging medical technologies. The public…
THE ACTO TIMES 